Intelligent Pharma
News & Events

News & Events

Events

  • February 21st-23rd 2017

    Tides Asia


    Come and meet us in Kyoto!


  • February 21st-24th 2017

    Drug discovery reinvented


    Meet Intelligent Pharma in Mexico


News

  • 01/06/2016

    Marie Curie Training Award


    Intelligent Pharma receives Marie Curie Training Award

    Intelligent Pharma is participating in a €3.8M Marie Curie Innovative Training Network (ITN) called TRAIN ‘Tribbles Research and Innovation Network’. Led by Dr. Ender Kiss-Toth (The University of Sheffield), the consortium includes companies and institutions from the UK, Spain, Germany, France, The Netherlands, Portugal, and Hungary. The work in this program will be undertaken by 15 PhD students who will investigate how dysregulated innate immune responses and metabolism promote the development and progression of cancer.


  • 09/05/2016

    Premio Caracter Empresa to Innovation in Catalunya


    Intelligent Pharma is awarded with the Premio Caracter Empresa to Innovation in Catalunya
    Barcelona, Spain, 9th May, 2016

    Intelligent Pharma has been recognized once more for its innovation capacity by CaixaBank, the Spanish Confederation of Business Organizations (CEOE), and Foment del Treball. The Innovation category of the Premio Caracter Empresa awards recognizes the best companies with outstanding projects, competitive advantages, and growth potential. Intelligent Pharma, from its headquarters at the PCB, has developed 10 leading technologies in computational chemistry.
    "For us, this award represents an important recognition for our day-to-day work. At Intelligent Pharma, we are working intensively on the research and development of new technologies that can help cure major diseases afflicting our society. Awards like this help us know that we are on the right track" said Dr. Ignasi Belda, CEO and founder of Intelligent Pharma.


  • 07/04/2016

    Intelligent Pharma receives the TECNIO certification


    Intelligent Pharma receives the TECNIO certification

     

    The Catalan Government has created the new TECNIO seal. The TECNIO seal certifies companies and academic groups that have developed innovative and high quality technologies ready to be commercialized. On April the 7th, Catalan ministry of Science and Business, Mr. Jordi Baiget, presented the first companies to obtain the TECNIO seal. Only three companies in Catalonia received the distinction.


  • 15/12/2015

    Intelligent Pharma opens a new office in Germany


    Intelligent Pharma recently opened a new office in Munich, Germany. This is the fifth international office that the company has set up in the same number of years. Intelligent Pharma currently has two European delegations in Heidelberg, Germany and the BioPark cluster in Welwyn Garden City, United Kingdom, and two offices in North America in Cambridge, Massachusetts, United States, and Calgary, Alberta, Canada, the latter specializing in petrochemical research.

    The new Munich office will enable the creation of a solid commercial platform for high value-added services in the pharmaceutical industry. The objective of the office is to increase brand visibility and market share in the Bavarian region.

    We chose Munich because it is an area with a very powerful industry, and our market share is still low in that region. Currently, we are the only service provider in computational chemistry with a presence in five countries and customers in twenty countries around the world", says Dr. Ignasi Belda, founder and CEO of Intelligent Pharma.


  • 15/10/2015

    Intelligent Pharma receives two grants


    Intelligent Pharma receives two grants

    Intelligent Pharma has recently received two grants to foster its internal R&D projects. One of the grants, A.E.E.S.D. - Impulso Tecnológico, has been awarded by the Spanish Ministry of Industry (MINETUR) to develop new, advanced computational chemistry technologies in the cloud, and the second, Torres Quevedo, has been awarded by the Spanish Ministry of Economy (MINECO) to enhance and further develop PYTHIA, our technology for the discovery of mechanisms of action. In total, both grants represent almost 600.000 €.